| Product Name | MF | CAS | Details |
|---|
| Donkey IgM | Details |
| 3-Indoleacetic acid | C10H9NO2 | 87-51-4 | Details |
| MAPK1, ERK2, PRKM1, PRKM2 MS Calibrator (25nmol) | Details |
| 4-tert-Butyl-3-fluorophenol | C10H13FO | 886842-69-9 | Details |
| Caerulein triammonium | C58H73N13O21S2 | 17650-98-5 | Details |
| 1-(Butan-2-yl)-1H-pyrazole-4-carbaldehyde | C8H12N2O | 1170169-27-3 | Details |
| COA4 protein (His tag) | Details |
| 2-(2,5-Dimethoxybenzenesulfonamido)acetic acid | C10H13NO6S | 781656-64-2 | Details |
| Carbamazepine-d2 | C15H12N2O | 1189902-21-3 | Details |
| 2-hydroxy-2-(3-nitrophenyl)acetic acid | C8H7NO5 | 42164-79-4 | Details |
| HBX | C13H4N4O | 40114-84-9 | Details |
| 2-Methyl-4-(1,3-oxazol-2-yl)aniline hydrochloride | C10H11ClN2O | 1803609-29-1 | Details |
| (H-Cys-Gly-OH)2 (Disulfide bond) | C10H18N4O6S2 | 7729-20-6 | Details |
| 3,3-Dimethyl-1-sulfanylbutan-2-one | C6H12OS | 88977-75-7 | Details |
| 3-Methylcyclopentylidene-[4-(4'-chlorophenyl)thiazol-2-yl]hydrazone hydrobromide | C15H16ClN3S | 1099614-81-9 | Details |
| Disperse Violet 27, Technical grade Dye content | C20H13NO3 | 12237-62-6 | Details |
| NDUFB7 antibody | Details |
| 3-[(1R)-1-Hydroxyethyl]phenol | C8H10O2 | 625852-10-0 | Details |
| 1-Carboxymethyl-pyrrolidine-3-carboxylic acid methyl ester | C8H13NO4 | 1427195-40-1 | Details |
| Resibufogenin | C24H32O4 | 465-39-4 | Details |
| Cephalexin sulfoxide | C16H17N3O5S | 56193-21-6 | Details |
| 2-Chloro-1-{4-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl}ethan-1-one | C9H6Cl2N2O | 1553611-49-6 | Details |
| 2-[(2-Chloropyrimidin-4-yl)(methyl)amino]acetic acid | C7H8ClN3O2 | 1803601-60-6 | Details |
| N-(5-Amino-2-fluorophenyl)-1-phenylmethanesulfonamide | C13H13FN2O2S | 926198-47-2 | Details |
| 2,4-Dichloro-5-fluorobenzyl alcohol | C7H5Cl2FO | 219765-56-7 | Details |
| (6-Fluoropyridin-3-yl)methanamine dihydrochloride | C6H9Cl2FN2 | 1955506-73-6 | Details |
| Phenyl α-D-thiomannopyranoside | C12H16O5S | 77481-62-0 | Details |
| Methyl 2-(2-Bromo-4-pyridyl)acetate | C8H8BrNO2 | 1234217-58-3 | Details |
| Tosufloxacin | C19H15F3N4O3 | 100490-36-6 | Details |
| N'-Hydroxyquinoline-2-carboximidamide | C10H9N3O | 72081-99-3 | Details |
| ZLN024 | C13H13BrN2OS | 723249-01-2 | Details |
| 2-Thiophenemethanol | C5H6OS | 636-72-6 | Details |
| 6-Chloro-2-hydroxyquinoline | C9H6ClNO | 1810-67-9 | Details |
| Methyl-β-cyclodextrin - 7 to 14 degree of substitution | C54H94O35 | 128446-36-6 | Details |
| 16a-Hydroxyestrone 16-b-D-glucuronide | C24H30O9 | 15270-34-5 | Details |
| Anti PACAP (1-15), humanSerum | Details |
| Sodium glycocholate hydrate | C26H46NNaO7 | 338950-81-5 | Details |
| 6-Fluoro-1,2,3,4-tetrahydroisoquinolin-7-ol hydrochloride | C9H10FNO.ClH | 2253641-23-3 | Details |
| LCBiot-VLDFAPPGA-OH | Details |
| ATP7B antibody | Details |
| ORF3 antibody | Details |
| 3,5-Dicyclopropyl-1H-1,2,4-triazole hydrochloride | C8H12ClN3 | 1423033-56-0 | Details |
| 1,8-Dichloropyrene | 89315-22-0 | Details |
| SUCLG2 antibody | Details |
| Recombinant Pseudomonas aeruginosa Major outer membrane lipoprotein (oprI) | Details |
| Hydromethylthionine | C16H19N3S | 613-11-6 | Details |
| Evenamide | C16H26N2O2 | 1092977-61-1 | Details |
| 2-((5-Chloro-2-methoxyphenyl)amino)-4-methyl-1,3-thiazole-5-carboxylic acid | C12H11ClN2O3S | 890082-10-7 | Details |
| 3-(4-Hydroxyphenyl)-1,1,3-trimethyl-5-indanol | C18H20O2 | 10527-11-4 | Details |
| 7-Amino-1,2,3,4-tetrahydronaphthol | C10H13NO | 214698-03-0 | Details |
| 5-(Methylamino)-2,3-dihydropyridazin-3-one | C5H7N3O | 1353498-86-8 | Details |
| SMC1 antibody | Details |
| TP53RK antibody | Details |
| 4-Amino-3-benzyl-3-methylbutan-2-ol | C12H19NO | 1483742-87-5 | Details |
| Dehydro indapamide-d3 | C16H14ClN3O3S | 1185057-48-0 | Details |
| 2-Chloro-5-(3,5-dimethyl-pyrazol-1-yl)-benzoic acid | C12H11ClN2O2 | 401827-60-9 | Details |
| 2-Chloro-1,3-propanediol | C3H7ClO2 | 497-04-1 | Details |
| 3-(4-Fluorophenyl)-3-methylbutanoic acid | C11H13FO2 | 339-34-4 | Details |
| N-[4-Chloro-2-methyl-3-(trifluoromethyl)phenyl]-2,2-dimethylpropanamide | C13H15ClF3NO | 112641-23-3 | Details |
| 1,7-Naphthyridine-3-carboxylic acid | C9H6N2O2 | 250674-49-8 | Details |
| 7-Methoxypyrazolo[1,5-a]pyridine-3-carboxylic acid | C9H8N2O3 | 1352395-45-9 | Details |
| 1-Methyl-3-[3-methyl-4-[4-[(trifluoromethyl)sulfonyl]phenoxy]phenyl]-1,3,5-triazine-2,4,6(1H,3H,5H)-trione | C18H14F3N3O6S | 69004-04-2 | Details |
| STK11IP antibody | Details |
| Monofucosyllacto-N-hexaose II | C46H78N2O35 | 56501-25-8 | Details |
| 3,6-Dimethylphenanthrene | C16H14 | 1576-67-6 | Details |
| AMPK antibody | Details |
| Tri-b-GalNAc-PEG3-azide | C70H125N13O31 | 2925590-71-0 | Details |
| 2-(5-Ethyl-4-methyl-4H-1,2,4-triazol-3-yl)acetonitrile | C7H10N4 | 2106335-49-1 | Details |
| [(2-Chloro-4-methylphenyl)sulfamoyl]dimethylamine | C9H13ClN2O2S | 1018154-46-5 | Details |
| ORM-10962 | C27H29N3O4 | 763926-98-3 | Details |
| 3-(Acetyloxy)-1-(2-(dimethylamino)ethyl)-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-6-(trifluromethyl)-2H-1-benzazepine-2-one | C24H27F3N2O4 | 138383-07-0 | Details |
| CST7 protein | Details |
| Aldol??495 inositol-phosphate, ammonium salt, Biosynth Patent: EP 2427431 and US 8940909 | C26H29ClN3O10P | 2484872-61-7 | Details |
| Epi-aszonalenin A | C25H25N3O3 | 908853-14-5 | Details |
| 3-(Trifluoromethyl)-1-azabicyclo[2.2.2]octan-3-amine dihydrochloride | C8H14ClF3N2 | 1803583-40-5 | Details |
| N-butyl(4-(2-pyridyl)piperazinyl)formamide | C14H22N4O | 335282-64-9 | Details |
| 4-(Trifluoromethoxy)-N'-{[2-(trifluoromethyl)phenyl]methyl}benzene-1-carboximidamide hydrochloride | C16H13ClF6N2O | 546114-56-1 | Details |
| 2,3-Dihydrospiro[indene-1,3'-pyrrolidine] hydrochloride | C12H16ClN | 81962-05-2 | Details |
| c3-Ethylbenzoic acid | C9H10O2 | 619-20-5 | Details |
| 7H-Pyrrolo[2,3-d]pyrimidine-4-carboxylic acid | C7H5N3O2 | 1005206-17-6 | Details |
| 2-[3-(Trifluoromethyl)phenyl]propan-1-amine hydrochloride | C10H13ClF3N | 79314-52-6 | Details |
| HADH2 antibody | Details |
| 3-Difluoromethanesulfinylaniline hydrochloride | C7H8ClF2NOS | 2193067-07-9 | Details |
| Benzyl({2-methyl-1-[(2-methylprop-2-en-1-yl)oxy]propan-2-yl})amine | C15H23NO | 1955547-80-4 | Details |
| 4-[(4-Fluorophenyl)methyl]-1,3-thiazol-2-amine | C10H9FN2S | 1087792-67-3 | Details |
| 5-(Pyrrolidin-1-ylmethyl)pyridin-2-amine | C10H15N3 | 913573-02-1 | Details |
| 4-Hydrazinyl-2-(pyridin-4-yl)-6-(trifluoromethyl)pyrimidine | C10H8F3N5 | 1334146-62-1 | Details |
| 4-Bromophenyl cyclohexyl ketone | C13H15BrO | 3277-79-0 | Details |
| Methyl 3-(4-methoxyphenyl)-2-methyl-3-oxopropanoate | C12H14O4 | 86109-34-4 | Details |
| tert-Butyl 4-amino-3-hydroxybenzoate | C11H15NO3 | 137066-33-2 | Details |
| 3',5'-Diprenyl-dihydroacacetin | C26H30O5 | 887594-71-0 | Details |
| 2-Amino-5-fluoro-6-nitro-1H-indole-3-carboxamide | C9H7FN4O3 | 139495-88-8 | Details |
| SRD5A1 antibody | Details |
| H-GLGDVDQLVK-OH | Details |
| 2-(4-(tert-butyl)phenoxy)(3-pyridyl) 4-(5-chloro-2-methylphenyl)piperazinyl ketone | C27H30ClN3O2 | 497060-69-2 | Details |
| Ethyl 3-[(tert-butoxy)amino]propanoate | C9H19NO3 | 1554968-59-0 | Details |
| tert-Butyl 4-methylpiperidine-4-carboxylate hydrochloride | C11H22ClNO2 | 1989672-82-3 | Details |
| Ethyl 4-cyano-3-nitrobenzoate | C10H8N2O4 | 321162-58-7 | Details |
| H-LADFADALEHPLR-OH | Details |
| Boc-C1-PEG2-C4-Cl | C14H27ClO4 | 1835705-53-7 | Details |
| Product Total： Product Page： | ||||
| 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 | ||||